CheckMate 214 Results Positive Overall - 102191


CheckMate 214 Results Positive Overall

Cancer-News has 158 videos Subscribe Here

Description: Dr. Scott S. Tykodi, MD reveals the results of the Checkmate - 214 trial with combined immunotherapy nivolumab plus ipilimumab and explains the positive results on objective response rate and prolonged progression-free survival compared to sunitinib in intermediate- and poor-risk patients with previously untreated advanced or metastatic renal cell carcinoma.
Shared By : Cancer-News
Posted on : 09/18/17
Added : 1 year ago
Category : Kidney Cancer


Nothing found.